Colfax Corp.’s DJO this week announced that it entered into a definitive agreement to acquire Mathys AG Bettlach for an undisclosed amount.
Mathys makes and distributes products for artificial joint replacement, synthetic bone graft solutions and sports medicine. The acquisition is expected to strengthen DJO’s patient-focused innovation pipeline and broaden its reconstructive portfolio.
“We are very pleased by this opportunity to enlarge our successful reconstructive product portfolio with Mathys’s complimentary surgical solutions and customer base, and even more excited about our ability to quickly advance our collective orthopedic leadership outside of the United States,” DJO CEO Brady Shirley said in a news release. “Mathys’s differentiated products, deep expertise and talented global team will help us accelerate our strategic imperative of delivering superior patient outcomes around the world.”
The transaction is expected to close in the third quarter of 2021, subject to regulatory approvals and other closing conditions.
“Combining these two leading orthopedic businesses into one global platform creates an exciting opportunity to build on the strengths of both Mathys and DJO in developing and delivering the next generation of orthopedic innovations,” Mathys CEO Benjamin Reinmann said. “I believe that our employees, customers and their patients will benefit from this combination which will create even greater opportunities for growth and continued success.”
